Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of clathrin-mediated endocytosis. [GOC:TermGenie]
Negative regulation of clathrin-dependent endocytosis is a complex process that ensures precise control over the uptake of extracellular molecules and membrane components into the cell. This process is essential for a wide range of cellular functions, including signal transduction, nutrient uptake, and immune response.
The core of clathrin-dependent endocytosis involves the formation of clathrin-coated pits, which are invaginations of the plasma membrane. These pits are assembled through the recruitment of clathrin, a protein that forms a lattice-like structure around the pit. Other key components include adaptor proteins, such as AP-2, which link cargo molecules to the clathrin lattice, and dynamin, a GTPase that constricts the neck of the pit, ultimately leading to the pinching off of the vesicle.
Negative regulation of clathrin-dependent endocytosis aims to ensure that this process is tightly controlled, preventing excessive or inappropriate internalization. This regulation can occur at multiple steps:
1. **Cargo Selection and Recruitment:** Negative regulators can interfere with the interaction of cargo with adaptor proteins, thus preventing their inclusion in the clathrin-coated pits. For example, some proteins can compete with cargo for binding sites on adaptor proteins, or they can induce conformational changes in the adaptor proteins, reducing their ability to bind cargo.
2. **Clathrin Coat Assembly:** Negative regulators can block the assembly of the clathrin lattice itself. Some proteins bind to clathrin and disrupt its polymerization, while others can inhibit the recruitment of adaptor proteins to the membrane, hindering the formation of the coat.
3. **Clathrin Pit Maturation:** Negative regulators can prevent the maturation of clathrin-coated pits, preventing them from progressing to the stage where they can be pinched off. For instance, some proteins can directly interact with dynamin, interfering with its ability to constrict the neck of the pit.
4. **Vesicle Uncoating:** Even after vesicle formation, some negative regulators can act to prevent the uncoating of the clathrin coat, leading to the accumulation of coated vesicles and inhibiting subsequent endocytic events.
The interplay of these regulatory mechanisms ensures that only the appropriate molecules are internalized at the right time and place. Dysregulation of negative regulation of clathrin-dependent endocytosis can lead to various cellular defects and disease states, highlighting the crucial role of this process in maintaining cellular homeostasis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sialidase-3 | A sialidase-3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UQ49] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
carzenide | sulfonamide | ||
zanamivir | Zanamivir: A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE. | guanidines | antiviral agent; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor |
oseltamivir | oseltamivir : A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza. Oseltamivir: An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE. | acetamides; amino acid ester; cyclohexenecarboxylate ester; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; environmental contaminant; prodrug; xenobiotic |
2-deoxy-2,3-dehydro-n-acetylneuraminic acid | 2-deoxy-2,3-dehydro-N-acetylneuraminic acid : N-Acetylneuraminic acid reduced across the 2,3-bond with loss of the hydroxy group at C-2; it is a minor component of body fluids although abundant in sialuria. 2-deoxy-2,3-dehydro-N-acetylneuraminic acid: also known as NeuAc2en, but this is also synonym for another compound | N-acetylneuraminic acids | |
bcx 1812 | 3-hydroxy monocarboxylic acid; acetamides; cyclopentanols; guanidines | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor | |
n-acetylneuraminic acid | N-acetylneuraminic acid : An N-acylneuraminic acid where the N-acyl group is specified as acetyl. N-Acetylneuraminic Acid: An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518) | N-acetylneuraminic acids | antioxidant; bacterial metabolite; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; human metabolite; mouse metabolite |
n-acetylneuraminic acid | N-acetyl-beta-neuraminic acid : N-Acetylneuraminic acid with beta configuration at the anomeric centre. | N-acetylneuraminic acid | epitope |
4-amino-2-deoxy-2,3-didehydro-n-acetylneuraminic acid | |||
bana 113 |